Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffold.
Herberich, B., Cao, G.Q., Chakrabarti, P.P., Falsey, J.R., Pettus, L., Rzasa, R.M., Reed, A.B., Reichelt, A., Sham, K., Thaman, M., Wurz, R.P., Xu, S., Zhang, D., Hsieh, F., Lee, M.R., Syed, R., Li, V., Grosfeld, D., Plant, M.H., Henkle, B., Sherman, L., Middleton, S., Wong, L.M., Tasker, A.S.(2008) J Med Chem 51: 6271-6279
- PubMed: 18817365 
- DOI: 10.1021/jm8005417
- Primary Citation of Related Structures:  
3DS6, 3DT1 - PubMed Abstract: 
Investigations into the structure-activity relationships (SAR) of a series of phthalazine-based inhibitors of p38 are described. These efforts originated from quinazoline 1 and through rational design led to the development of a series of orally bioavailable, potent, and selective inhibitors ...